Codexis (CDXS) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

CDXS Stock Forecast

Codexis stock forecast is as follows: an average price target of $11.00 (represents a 122.22% upside from CDXS’s last price of $4.95) and a rating consensus of 'Buy', based on 3 wall street analysts offering a 1-year stock forecast.

CDXS Price Target

The average price target for Codexis (CDXS) is $11.00 based on 1-year price targets from 3 Wall Street analysts in the past 3 months, with a price target range of $11.00 to $11.00. This represents a potential 122.22% upside from CDXS's last price of $4.95.

CDXS Analyst Ratings

Buy

According to 3 Wall Street analysts, Codexis's rating consensus is 'Buy'. The analyst rating breakdown for CDXS stock is 0 'Strong Buy' (0.00%), 2 'Buy' (66.67%), 1 'Hold' (33.33%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Codexis Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
May 30, 2024	Kristen Kluska	Cantor Fitzgerald	$11.00	$3.19	244.83%	122.22%

The latest Codexis stock forecast, released on May 30, 2024 by Kristen Kluska from Cantor Fitzgerald, set a price target of $11.00, which represents a 244.83% increase from the stock price at the time of the forecast ($3.19), and a 122.22% increase from CDXS last price ($4.95).

Codexis Price Target by Period

	1M	3M	12M
# Anlaysts	-	-	1
Avg Price Target	-	-	$11.00
Last Closing Price	$4.95	$4.95	$4.95
Upside/Downside	-100.00%	-100.00%	122.22%

In the current month, the average price target of Codexis stock is -, according to 0 Wall Street analyst offering twelve months forecast. The average price target represents a -100.00% decrease as opposed to Codexis's last price of $4.95. This month's average price target is down NaN% compared to last quarter, and down -100.00% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Aug 19, 2024	Benchmark	Positive	Hold	Downgrade
Aug 15, 2024	Piper Sandler	Overweight	Overweight	Hold
May 30, 2024	Cantor Fitzgerald		Overweight	Initialise
Feb 29, 2024	Benchmark		Positive	Upgrade
Jul 14, 2022	Piper Sandler	Overweight	Overweight	Hold
Mar 31, 2022	Piper Sandler		Overweight	Initialise

Codexis's last stock rating was published by Benchmark on Aug 19, 2024. The company Downgrade its CDXS rating from "Positive" to "Hold".

Codexis Financial Forecast

Codexis Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	$9.28M	$21.32M	$12.98M	$30.38M	$34.47M	$38.41M	$35.34M	$24.50M	$36.77M	$25.45M	$18.03M	$21.03M	$18.39M	$14.97M	$14.67M	$18.65M	$21.91M
Avg Forecast	$20.65M	$18.55M	$18.05M	$16.95M	$20.54M	$17.47M	$15.09M	$14.00M	$27.41M	$11.49M	$7.82M	$13.31M	$19.90M	$10.03M	$19.83M	$14.09M	$28.93M	$30.94M	$38.11M	$28.59M	$23.20M	$28.59M	$18.30M	$14.42M	$20.88M	$15.91M	$11.24M	$12.73M	$21.38M	$16.75M
High Forecast	$23.86M	$21.44M	$20.86M	$19.59M	$23.74M	$20.19M	$17.44M	$14.01M	$31.32M	$13.28M	$7.82M	$13.31M	$20.56M	$10.03M	$22.92M	$16.29M	$33.44M	$30.94M	$38.11M	$28.59M	$23.20M	$28.59M	$18.30M	$14.42M	$20.88M	$15.91M	$11.24M	$12.73M	$21.38M	$16.75M
Low Forecast	$17.03M	$15.30M	$14.89M	$13.98M	$16.94M	$14.41M	$12.45M	$13.98M	$21.64M	$9.48M	$7.82M	$13.31M	$19.23M	$10.03M	$16.36M	$11.62M	$23.87M	$30.94M	$38.11M	$28.59M	$23.20M	$28.59M	$18.30M	$14.42M	$20.88M	$15.91M	$11.24M	$12.73M	$21.38M	$16.75M
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	15	9	9	16	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	0.92%	1.08%	0.92%	1.05%	1.11%	1.01%	1.24%	1.06%	1.29%	1.39%	1.25%	1.01%	1.16%	1.33%	1.15%	0.87%	1.31%

Codexis's average Quarter revenue forecast for Dec 23 based on 4 analysts is $19.90M, with a low forecast of $19.23M, and a high forecast of $20.56M. CDXS's average Quarter revenue forecast represents a 114.52% increase compared to the company's last Quarter revenue of $9.28M (Sep 23).

Codexis EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	15	9	9	16	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	-	$-32.06M	$-12.63M	$-23.52M	$-6.92M	$-8.02M	$-2.61M	$-8.39M	$-8.26M	$3.83M	$-2.67M	$-7.58M	$-2.68M	$-4.91M	$-4.87M	$-6.25M	$936.00K	$1.99M
Avg Forecast	$-5.89M	$-5.29M	$-5.15M	$-4.83M	$-5.86M	$-4.98M	$-4.30M	$-3.99M	$-7.82M	$-3.28M	$-2.23M	$-11.24M	$-5.68M	$-2.86M	$-5.66M	$-10.22M	$-13.36M	$-9.85M	$-12.13M	$-10.93M	$-7.39M	$-9.10M	$-5.83M	$-10.09M	$-6.65M	$-5.07M	$-3.58M	$-7.39M	$-6.81M	$-5.33M
High Forecast	$-4.86M	$-4.36M	$-4.25M	$-3.99M	$-4.83M	$-4.11M	$-3.55M	$-3.99M	$-6.17M	$-2.70M	$-2.23M	$-8.99M	$-5.49M	$-2.86M	$-4.67M	$-8.17M	$-10.69M	$-9.85M	$-12.13M	$-8.74M	$-7.39M	$-9.10M	$-5.83M	$-8.07M	$-6.65M	$-5.07M	$-3.58M	$-5.91M	$-6.81M	$-5.33M
Low Forecast	$-6.81M	$-6.11M	$-5.95M	$-5.59M	$-6.77M	$-5.76M	$-4.97M	$-3.99M	$-8.93M	$-3.79M	$-2.23M	$-13.49M	$-5.86M	$-2.86M	$-6.54M	$-12.26M	$-16.03M	$-9.85M	$-12.13M	$-13.11M	$-7.39M	$-9.10M	$-5.83M	$-12.10M	$-6.65M	$-5.07M	$-3.58M	$-8.86M	$-6.81M	$-5.33M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	11.20%	2.23%	2.30%	0.52%	0.81%	0.22%	0.77%	1.12%	-0.42%	0.46%	0.75%	0.40%	0.97%	1.36%	0.85%	-0.14%	-0.37%

2 analysts predict CDXS's average Quarter EBITDA for Dec 21 to be $-7.39M, with a high of $-7.39M and a low of $-7.39M. This is -292.73% lower than Codexis's previous annual EBITDA (Sep 21) of $3.83M.

Codexis Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	15	9	9	16	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	-	$-34.91M	$-11.52M	$-22.62M	$-12.61M	$-9.99M	$-2.64M	$-8.36M	$-10.19M	$2.24M	$-4.26M	$-9.07M	$-3.92M	$-6.09M	$-6.34M	$-7.65M	$-635.00K	$343.00K
Avg Forecast	$-12.25M	$-12.25M	$-12.97M	$-12.97M	$-11.53M	$-11.96M	$-12.39M	$-13.11M	$-2.61M	$-17.20M	$-19.00M	$-11.31M	$-8.95M	$-23.36M	$-15.40M	$-10.28M	$-16.41M	$-13.11M	$-9.76M	$-10.99M	$-14.08M	$-6.53M	$-12.23M	$-11.79M	$-6.54M	$-5.98M	$-11.49M	$-8.67M	$1.76M	$-4.08M
High Forecast	$-9.46M	$-9.46M	$-10.01M	$-10.01M	$-8.90M	$-9.24M	$-9.57M	$-12.29M	$5.22M	$-13.28M	$-14.67M	$-9.05M	$-1.68M	$-18.04M	$-11.89M	$-8.22M	$-13.12M	$-13.11M	$-9.76M	$-8.80M	$-14.08M	$-6.53M	$-12.23M	$-9.43M	$-6.54M	$-5.98M	$-11.49M	$-6.94M	$1.76M	$-4.08M
Low Forecast	$-14.72M	$-14.72M	$-15.59M	$-15.59M	$-13.86M	$-14.38M	$-14.90M	$-13.93M	$-14.36M	$-20.68M	$-22.84M	$-13.57M	$-17.35M	$-28.09M	$-18.51M	$-12.34M	$-19.69M	$-13.11M	$-9.76M	$-13.19M	$-14.08M	$-6.53M	$-12.23M	$-14.15M	$-6.54M	$-5.98M	$-11.49M	$-10.41M	$1.76M	$-4.08M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.49%	0.75%	2.20%	0.77%	0.76%	0.27%	0.76%	0.72%	-0.34%	0.35%	0.77%	0.60%	1.02%	0.55%	0.88%	-0.36%	-0.08%

Codexis's average Quarter net income forecast for Dec 21 is $-14.08M, with a range of $-14.08M to $-14.08M. CDXS's average Quarter net income forecast represents a -727.24% decrease compared to the company's last Quarter net income of $2.24M (Sep 21).

Codexis SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	15	9	9	16	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	-	$12.30M	$13.37M	$15.40M	$12.31M	$13.50M	$10.66M	$15.71M	$11.72M	$13.41M	$12.79M	$11.40M	$8.74M	$8.80M	$8.52M	$8.99M	$7.32M	$7.87M
Avg Forecast	$10.63M	$9.55M	$9.29M	$8.73M	$10.57M	$9.00M	$7.77M	$7.21M	$14.11M	$5.91M	$4.03M	$6.85M	$10.25M	$5.16M	$10.21M	$7.26M	$18.87M	$15.44M	$19.02M	$20.66M	$11.58M	$14.27M	$9.13M	$7.20M	$10.42M	$7.94M	$5.61M	$-2.24M	$10.67M	$8.36M
High Forecast	$12.29M	$11.04M	$10.74M	$10.08M	$12.22M	$10.40M	$8.98M	$7.21M	$16.12M	$6.83M	$4.03M	$6.85M	$10.59M	$5.16M	$11.80M	$8.38M	$22.65M	$15.44M	$19.02M	$24.80M	$11.58M	$14.27M	$9.13M	$7.20M	$10.42M	$7.94M	$5.61M	$-1.79M	$10.67M	$8.36M
Low Forecast	$8.77M	$7.88M	$7.67M	$7.20M	$8.72M	$7.42M	$6.41M	$7.20M	$11.14M	$4.88M	$4.03M	$6.85M	$9.90M	$5.16M	$8.42M	$5.98M	$15.10M	$15.44M	$19.02M	$16.53M	$11.58M	$14.27M	$9.13M	$7.20M	$10.42M	$7.94M	$5.61M	$-2.69M	$10.67M	$8.36M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	2.38%	1.31%	2.12%	0.65%	0.87%	0.56%	0.76%	1.01%	0.94%	1.40%	1.58%	0.84%	1.11%	1.52%	-4.01%	0.69%	0.94%

Codexis's average Quarter SG&A projection for Dec 23 is $10.25M, based on 4 Wall Street analysts, with a range of $9.90M to $10.59M. The forecast indicates a -16.71% fall compared to CDXS last annual SG&A of $12.30M (Sep 23).

Codexis EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	1	1	1	1	1	1	1	3	6	3	2	2	4	2	2	2	1	1	1	1	2	2	2	2	9	15	9	9	16	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	-	$-0.50	$-0.17	$-0.34	$-0.19	$-0.15	$-0.04	$-0.13	$-0.16	$0.03	$-0.07	$-0.14	$-0.06	$-0.10	$-0.11	$-0.13	$-0.01	$0.01
Avg Forecast	$-0.17	$-0.17	$-0.18	$-0.18	$-0.16	$-0.17	$-0.17	$-0.18	$-0.04	$-0.24	$-0.26	$-0.18	$-0.12	$-0.32	$-0.21	$-0.31	$-0.23	$-0.19	$-0.14	$-0.19	$-0.20	$-0.09	$-0.17	$-0.20	$-0.09	$-0.09	$-0.16	$-0.13	$0.03	$-0.06
High Forecast	$-0.13	$-0.13	$-0.14	$-0.14	$-0.12	$-0.13	$-0.13	$-0.17	$0.07	$-0.18	$-0.20	$-0.14	$-0.02	$-0.25	$-0.17	$-0.24	$-0.17	$-0.19	$-0.14	$-0.19	$-0.20	$-0.09	$-0.17	$-0.20	$-0.09	$-0.09	$-0.16	$-0.13	$0.03	$-0.06
Low Forecast	$-0.20	$-0.20	$-0.22	$-0.22	$-0.19	$-0.20	$-0.21	$-0.19	$-0.20	$-0.29	$-0.32	$-0.22	$-0.24	$-0.39	$-0.26	$-0.37	$-0.27	$-0.19	$-0.14	$-0.19	$-0.20	$-0.09	$-0.17	$-0.20	$-0.09	$-0.09	$-0.16	$-0.13	$0.03	$-0.06
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	-	1.54%	0.80%	1.10%	0.84%	0.81%	0.29%	0.70%	0.80%	-0.32%	0.40%	0.69%	0.65%	1.18%	0.67%	1.00%	-0.40%	-0.17%

According to 2 Wall Street analysts, Codexis's projected average Quarter EPS for Dec 21 is $-0.20, with a low estimate of $-0.20 and a high estimate of $-0.20. This represents a -766.67% decrease compared to CDXS previous annual EPS of $0.03 (Sep 21).

Codexis Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
STTK	Shattuck Labs	$1.15	$12.00	943.48%	Hold
NKTX	Nkarta	$2.27	$21.60	851.54%	Buy
IPSC	Century Therapeutics	$1.17	$5.00	327.35%	Buy
CGEM	Cullinan Oncology	$11.49	$34.00	195.91%	Buy
KZR	Kezar Life Sciences	$6.52	$17.50	168.40%	Buy
FHTX	Foghorn Therapeutics	$5.51	$14.00	154.08%	Buy
NUVB	Nuvation Bio	$2.81	$7.00	149.11%	Buy
MLYS	Mineralys Therapeutics	$12.35	$30.00	142.91%	Buy
CDXS	Codexis	$5.63	$11.00	95.38%	Buy
NRIX	Nurix Therapeutics	$21.18	$32.67	54.25%	Buy
LYEL	Lyell Immunopharma	$0.65	$1.00	53.85%	Hold
RVMD	Revolution Medicines	$45.16	$65.67	45.42%	Buy
KYMR	Kymera Therapeutics	$42.30	$58.60	38.53%	Buy

CDXS Forecast FAQ

Is Codexis a good buy?

Yes, according to 3 Wall Street analysts, Codexis (CDXS) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 2 'Buy' recommendations, accounting for 66.67% of CDXS's total ratings.

What is CDXS's price target?

Codexis (CDXS) average price target is $11 with a range of $11 to $11, implying a 122.22% from its last price of $4.95. The data is based on 3 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Codexis stock go up soon?

According to Wall Street analysts' prediction for CDXS stock, the company can go up by 122.22% (from the last price of $4.95 to the average price target of $11), up by 122.22% based on the highest stock price target, and up by 122.22% based on the lowest stock price target.

Can Codexis stock reach $7?

CDXS's average twelve months analyst stock price target of $11 supports the claim that Codexis can reach $7 in the near future.

What are Codexis's analysts' financial forecasts?

Codexis's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $67.1M (high $75.38M, low $57.79M), average EBITDA is $-19.139M (high $-16.483M, low $-21.5M), average net income is $-48.982M (high $-39.995M, low $-57.06M), average SG&A $34.55M (high $38.81M, low $29.75M), and average EPS is $-0.68 (high $-0.555, low $-0.792). CDXS's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $74.2M (high $85.75M, low $61.21M), average EBITDA is $-21.164M (high $-17.457M, low $-24.458M), average net income is $-50.422M (high $-38.943M, low $-60.625M), average SG&A $38.2M (high $44.15M, low $31.51M), and average EPS is $-0.7 (high $-0.541, low $-0.842).

Did the CDXS's actual financial results beat the analysts' financial forecasts?

Based on Codexis's last annual report (Dec 2022), the company's revenue was $138.59M, beating the average analysts forecast of $126.56M by 9.50%. Apple's EBITDA was $-28.547M, missing the average prediction of $-46.273M by -38.31%. The company's net income was $-33.592M, missing the average estimation of $-50.273M by -33.18%. Apple's SG&A was $52.17M, missing the average forecast of $74M by -29.50%. Lastly, the company's EPS was $-0.51, missing the average prediction of $-0.738 by -30.85%. In terms of the last quarterly report (Sep 2023), Codexis's revenue was $9.28M, missing the average analysts' forecast of $10.03M by -7.52%. The company's EBITDA was $-32.06M, beating the average prediction of $-2.861M by 1020.50%. Codexis's net income was $-34.908M, beating the average estimation of $-23.359M by 49.44%. The company's SG&A was $12.3M, beating the average forecast of $5.16M by 138.20%. Lastly, the company's EPS was $-0.5, beating the average prediction of $-0.324 by 54.18%